Skip to content

Antibiotics for acute otitis media in children less than 2 years of age.

Primary-care-based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under two years

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON26781
Enrollment
160
Registered
2008-08-29
Start date
1996-02-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute otitis media in general practice, antibiotics, placebo, infants acute middenoorontsteking in huisartsenpraktijk, antibiotica en placebo, kinderen onder de 2 jaar.

Interventions

Amoxicillin suspension 40mg/kg/day in three divide doses for 10 days or placebo suspension.

Sponsors

Julius Center for Health Sciences and Primary Care, UMC Utrecht
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children aged 6 months to two years with acute otitis media in general practice

Exclusion criteria

Exclusion criteria: 1. Antibiotic treatment in de preceding 4 weeks 2. Allergy to amoxicillin 3. Compromised immunity 4. Craniofacial abnormalities 5. Down's syndrome 6. Being entered in this study before.

Design outcomes

Primary

MeasureTime frame
Persistent symptoms at day 4, assessed by the doctor and defined as persistent earache, fever, crying or being irritable

Secondary

MeasureTime frame
- Clinical treatment failure at day 11 - Duration of fever or/of pain/crying - The mean number of doses of analgesics given - The percentage of children with middle ear effusion at 6 weeks, 3 months and 6 months - Adverse effects

Contacts

Public ContactR.A.M.J. Damoiseaux
R.A.M.J.Damoiseaux@umcutrecht.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)